We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

BioTek Launches Enhanced SiLA Compliant Software

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

LHC™ SiLA is a Liquid Handling Control Software that allows any BioTek LHC-controlled washer or dispenser to be integrated into a robotic system with SiLA compliance, equipping users with more flexibility in system configuration compared to conventional instrument drivers.

Compatible instruments include EL406, 405 Touch, 405 LS, ELx405 Select Deep Well, MultiFlo and MultiFlo FX. BioTek's LHC™ SiLA driver was developed in accordance with the Consortium for Standardization in Lab Automation's published set of universal methods for microplate washers and dispensers.

Important benefits include:
• Total flexibility in instrument component and automated system selection-users choose the best instrument for assay vs. being limited to what can be integrated into current systems.
• Fast, cost effective and seamless integration with automated systems.
• Conforms to international standards set forth by the Consortium for Standardization in Lab Automation creating open connectivity in lab automation.

The Consortium for Standardization in Lab Automation (more commonly known as SiLA) develops and introduces new interface and data management standards allowing rapid integration of lab automation systems. SiLA's mission is to establish international standards which create open connectivity in lab automation.

SiLA is a not-for-profit membership corporation with a global footprint open to institutions, corporations and individuals active in the life science lab automation industry.

SiLA compliance is quickly becoming a requirement for new instrument purchases in the labs of major pharmaceutical companies.